LPCN
LipocineANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
LPCN vs peer average
95/100
LPCN vs. peer average (A vs. F)
Grade spread
C 1 · D 1 · F 9
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
BTAI is the first available peer comparator.
BioXcel is a useful binary-event biotech peer because valuation is also heavily shaped by clinical outcome credibility and financing access, though it is not a close product analog to LPCN 1154.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LPCN
Lipocine
BTAI
BioXcel Therapeutics
Grade
A
F
Momentum
100
10
Value
57
41
Sentiment
45
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs BTAI
LPCN / BTAI
Grade Position
Above peers
LPCN vs. peer average (A vs. F)
95/100
Momentum
100
LPCNValue
57
LPCNSentiment
45
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LPCN
BTAI is the first peer returned for this comparison set.